Intralymphatic immunotherapy: Time interval between injections is essential

Intralymphatic immunotherapy: Time interval between injections is essential

Show other versions (1)

Bibliographic Details
Main Authors:	Kündig, T, Johansen, P, Bachmann, M, Cardell, L, Senti, G
Format:	Journal article
Language:	English
Published:	2014

Similar Items

Intralymphatic immunotherapy: time interval between injections is essential.
by: Kündig, T, et al.
Published: (2014)

Intralymphatic immunotherapy
by: Gabriela Senti, et al.
Published: (2015-01-01)

Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans
by: Alexandra Chabot, et al.
Published: (2022-03-01)

Intralymphatic immunization enhances DNA vaccination.
by: Maloy, K, et al.
Published: (2001)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
by: Klimek, L, et al.
Published: (2014)

Evaluation of Intralymphatic Immunotherapy in Allergic Rhinitis Patients: A Systematic Review and Meta-analysis
by: Sijie Jiang, et al.
Published: (2023-01-01)

Intralymphatic Immunotherapy With Autologous Semen in a Korean Man With Post-Orgasmic Illness Syndrome
by: Tae Beom Kim, MD, PhD, et al.
Published: (2018-06-01)

Intralymphatic immunotherapy with tyrosine-adsorbed allergens: a double-blind, placebo-controlled trial
by: Hye Jung Park, et al.
Published: (2021-06-01)

Novel allergen-independent immunotherapy: positive data from a phase Ila pilot study with CpG contained in virus-like particles
by: Bull, C, et al.
Published: (2007)

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
by: Senti, G, et al.
Published: (2009)

Oral papillary intralymphatic angioendothelioma: A case report and literature review
by: Peng Ye, et al.
Published: (2022-11-01)

Allergen-specific immunotherapy: regulatory T cells or allergen-specific IgG?
by: Kündig, T, et al.
Published: (2010)

Intralymphatic Immunotherapy with Ultrasound Guidance Seems to Be Associated with Improved Clinical Effect in Canine Atopic Dermatitis—A Retrospective Study of 109 Cases
by: Nina Maria Fischer, et al.
Published: (2024-10-01)

Clinical grade OK432-activated dendritic cells: in vitro characterization and tracking during intralymphatic delivery.
by: West, E, et al.
Published: (2009)

Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.
by: Keisuke Kirita, et al.
Published: (2013-01-01)

White Globe Appearance–Like Findings Indicating Intralymphatic Cancer Involvement Beneath the Epithelium in Gastric Cancer
by: Hiroki Maruyama, et al.
Published: (2024-01-01)

Strong ERG Positivity in Papillary Intralymphatic Angioendothelioma of the Testis of a 24-Year-Old Male: A Case Report
by: Anne M. Schultheis, et al.
Published: (2013-01-01)

Dust mite allergy - New treatment options
by: Haug, S, et al.
Published: (2007)

Dust mite allergy - new treatment option
by: Haug, S, et al.
Published: (2007)

Inflammasome activation and IL-1β target IL-1α for secretion as opposed to surface expression.
by: Fettelschoss, A, et al.
Published: (2011)

T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions
by: Alvaro Teijeira, et al.
Published: (2017-01-01)

IgG-mediated down-regulation of IgE bound to mast cells: A potential novel mechanism of allergen-specific desensitization
by: Uermösi, C, et al.
Published: (2014)

IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization.
by: Uermösi, C, et al.
Published: (2014)

Modelling the impact of sublingual immunotherapy versus subcutaneous immunotherapy on patient travel time and CO2 emissions in Sweden
by: Lars-Olaf Cardell, et al.
Published: (2024-01-01)

A double-blind, placebo-controlled phase IIa study investigating CYT003-QbG10 as a novel allergen-independent immunotherapy in patients suffering from grass pollen allergy
by: Senti, G, et al.
Published: (2007)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
by: Klimek, L, et al.
Published: (2018)

Injecting nanoparticles into immunotherapy
by: Sarah Webb
Published: (2017-07-01)

Dependence of scar contrast in LGE images on the time interval after contrast injection
by: Marrouche Nassir F, et al.
Published: (2011-02-01)

In vivo versus in vitro assays for assessment of T- and B- cell function.
by: Bachmann, M, et al.
Published: (1994)

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
by: Beatriz Tavira, et al.
Published: (2018-01-01)

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
by: Sara Puente-Marin, et al.
Published: (2023-02-01)

Piglets' acute responses to local anesthetic injection and surgical castration: Effects of the injection method and interval between injection and castration
by: Mathilde Coutant, et al.
Published: (2022-09-01)

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
by: Cardell LO, et al.
Published: (2024-06-01)

Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma
by: Marina Tusup, et al.
Published: (2021-01-01)

A double-blind, placebo-controlled phase Ila study investigating CYT003-QbG10 as a novel immunotherapy in patients suffering from house dust mite allergy
by: Kuendig, T, et al.
Published: (2007)

Immunotherapies: cause for measured optimism.
by: Jennings, G, et al.
Published: (2002)

Active immunotherapy for chronic diseases.
by: Bachmann, M, et al.
Published: (2013)

Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
by: Kündig, T, et al.
Published: (2006)

Interval design to identify the optimal biological dose for immunotherapy
by: Yeonhee Park
Published: (2022-12-01)

Identification of essential genes for cancer immunotherapy
by: Patel, Shashank J., et al.
Published: (2018)